Provided by Tiger Trade Technology Pte. Ltd.

20/20 BIOLABS INC

0.5543
+0.04027.82%
Post-market: 0.55840.0041+0.74%19:42 EDT
Volume:230.86K
Turnover:132.10K
Market Cap:6.79M
PE:-0.55
High:0.6436
Open:0.5241
Low:0.5045
Close:0.5141
52wk High:50.00
52wk Low:0.4011
Shares:12.25M
Float Shares:10.85M
Volume Ratio:1.92
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9997
EPS(LYR):-0.7600
ROE:-331.22%
ROA:-62.37%
PB:4.19
PE(LYR):-0.73

Loading ...

Company Profile

Company Name:
20/20 BIOLABS INC
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
9
Office Location:
15810 Gaither Road,Suite 235,Gaithersburg,Maryland,United States
Zip Code:
20877
Fax:
- -
Introduction:
20/20 Biolabs, Inc. was incorporated in Delaware on August 7, 2000. The company develops and commercializes AI-driven, laboratory-based blood tests focused on early detection and prevention of cancer and chronic diseases. Under its OneTest brand, it offers two main test families: OneTest for Cancer, a multi-cancer early detection blood test, and OneTest for Longevity, expected to launch in the first half of 2026. Both tests are performed at the company's CAP-accredited and CLIA-licensed laboratory in Gaithersburg, Maryland, which also houses a clinical laboratory innovation accelerator designed for diagnostic startups.

Directors

Name
Position
John G. Compton
Chairman of the Board and Independent Director
Jonathan Cohen
Director,Chief Executive Officer and President
John W. Rollins
Independent Director
Michael A. Ross
Independent Director
Prasanth Reddy
Independent Director
Richard M. Cohen
Independent Director

Shareholders

Name
Position
Jonathan Cohen
Director,Chief Executive Officer and President
Jiming Zhou
Chief Operating Officer
Alan B. Bergman
Chief Financial Officer
Michael Lebowitz
Chief Scientific Officer
Ron Baker
Chief Business Officer